{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T08:09:43Z","timestamp":1778486983884,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s12664-025-01802-7","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:25:37Z","timestamp":1749860737000},"page":"341-343","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intravenous iron in ulcerative colitis\u2014Raising the (iron) bar"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1039-6251","authenticated-orcid":false,"given":"Jimmy K.","family":"Limdi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,14]]},"reference":[{"key":"1802_CR1","doi-asserted-by":"publisher","first-page":"175628482210784","DOI":"10.1177\/17562848221078456","volume":"15","author":"A Kumar","year":"2022","unstructured":"Kumar A, Cole A, Segal J, Smith P, Limdi JK. A review of the therapeutic management of Crohn\u2019s disease. Therap Adv Gastroenterol. 2022;15:17562848221078456.","journal-title":"Therap Adv Gastroenterol"},{"key":"1802_CR2","doi-asserted-by":"publisher","first-page":"175628482211381","DOI":"10.1177\/17562848221138160","volume":"15","author":"N Aslam","year":"2022","unstructured":"Aslam N, Lo SW, Sikafi R,\u00a0et al. A review of the therapeutic management of ulcerative colitis. Therap Adv Gastroenterol. 2022;15:17562848221138160.","journal-title":"Therap Adv Gastroenterol"},{"issue":"1","key":"1802_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ecco-jcc\/jjad108","volume":"18","author":"H Gordon","year":"2024","unstructured":"Gordon H, Burisch J, Ellul P,\u00a0et al. ECCO guidelines on extraintestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2024;18:1\u201337.","journal-title":"J Crohns Colitis"},{"key":"1802_CR4","doi-asserted-by":"crossref","unstructured":"Lamb CA, Kennedy NA, Raine T, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68 Suppl 3:s1\u2013s106.","DOI":"10.1136\/gutjnl-2019-318484"},{"issue":"10270","key":"1802_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0140-6736(20)32594-0","volume":"397","author":"SR Pasricha","year":"2021","unstructured":"Pasricha SR, Tye-Din J, Muckenthaler MU, Swinkels DW. Iron deficiency. Lancet. 2021;397:233\u201348.","journal-title":"Lancet"},{"key":"1802_CR6","doi-asserted-by":"crossref","unstructured":"Malesza IJ, Bartkowiak-Wieczorek J, Winkler-Galicki J, et al. The dark side of iron: the relationship between iron, inflammation and gut microbiota in selected diseases associated with iron deficiency anaemia-a narrative review. Nutrients. 2022;14:3478.","DOI":"10.3390\/nu14173478"},{"issue":"3","key":"1802_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/gut.2010.216929","volume":"60","author":"T Werner","year":"2011","unstructured":"Werner T, Wagner SJ, Martinez I,\u00a0et al. Depletion of luminal iron alters the gut microbiota and prevents Crohn\u2019s disease-like ileitis. Gut. 2011;60:325\u201333.","journal-title":"Gut"},{"issue":"5","key":"1802_CR8","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1136\/gutjnl-2015-309940","volume":"66","author":"T Lee","year":"2017","unstructured":"Lee T, Clavel T, Smirnov K,\u00a0et al. Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017;66:863\u201371.","journal-title":"Gut"},{"issue":"3","key":"1802_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.crohns.2011.09.010","volume":"6","author":"TW Lee","year":"2012","unstructured":"Lee TW, Kolber MR, Fedorak RN, van Zanten SV. Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis. J Crohns Colitis. 2012;6:267\u201375.","journal-title":"J Crohns Colitis"},{"issue":"2","key":"1802_CR10","doi-asserted-by":"publisher","first-page":"e2308","DOI":"10.1097\/MD.0000000000002308","volume":"95","author":"S Bonovas","year":"2016","unstructured":"Bonovas S, Fiorino G, Allocca M,\u00a0et al. Intravenous versus oral iron for the treatment of anemia in inflammatory bowel disease: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2016;95:e2308.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"1802_CR11","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1016\/S2352-3026(19)30264-9","volume":"7","author":"M Auerbach","year":"2020","unstructured":"Auerbach M, Gafter-Gvili A, Macdougall IC. Intravenous iron: a framework for changing the management of iron deficiency. Lancet Haematol. 2020;7:e342\u201350.","journal-title":"Lancet Haematol"},{"key":"1802_CR12","doi-asserted-by":"publisher","unstructured":"Kochai AR, Mangipudi UK, Bhatia P, et al. Effectiveness and safety of intravenous iron in ulcerative colitis: A real-world study of impact of disease activity and iron preparations. Indian J Gastroenterol. 2025. https:\/\/doi.org\/10.1007\/s12664-025-01775-7.","DOI":"10.1007\/s12664-025-01775-7"},{"issue":"4","key":"1802_CR13","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.gie.2019.11.032","volume":"91","author":"JK Limdi","year":"2020","unstructured":"Limdi JK, Picco M, Farraye FA. A review of endoscopic scoring systems and their importance in a treat-to-target approach in inflammatory bowel disease (with videos). Gastrointest Endosc. 2020;91:733\u201345.","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"1802_CR14","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1111\/j.1572-0241.2007.01744.x","volume":"103","author":"S Kulnigg","year":"2008","unstructured":"Kulnigg S, Stoinov S, Simanenkov V,\u00a0et al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol. 2008;103:1182\u201392.","journal-title":"Am J Gastroenterol"},{"key":"1802_CR15","doi-asserted-by":"crossref","unstructured":"Evstatiev R, Marteau P, Iqbal T, et al. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology. 2011;141:846\u201353, e1\u20132.","DOI":"10.1053\/j.gastro.2011.06.005"},{"issue":"3","key":"1802_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.cgh.2012.10.013","volume":"11","author":"R Evstatiev","year":"2013","unstructured":"Evstatiev R, Alexeeva O, Bokemeyer B,\u00a0et al. Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2013;11:269\u201377.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"1802_CR17","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1080\/00365521.2016.1196496","volume":"51","author":"JF Dahlerup","year":"2016","unstructured":"Dahlerup JF, Jacobsen BA, van der Woude J, Bark LA, Thomsen LL, Lindgren S. High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23. Scand J Gastroenterol. 2016;51:1332\u20138.","journal-title":"Scand J Gastroenterol"},{"issue":"9","key":"1802_CR18","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1080\/00365521.2018.1498914","volume":"53","author":"J Stein","year":"2018","unstructured":"Stein J, Walper A, Klemm W, Farrag K, Aksan A, Dignass A. Safety and efficacy of intravenous iron isomaltoside for correction of anaemia in patients with inflammatory bowel disease in everyday clinical practice. Scand J Gastroenterol. 2018;53:1059\u201365.","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"1802_CR19","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/apt.15386","volume":"50","author":"TE Detlie","year":"2019","unstructured":"Detlie TE, Lindstrom JC, Jahnsen ME,\u00a0et al. Incidence of hypophosphatemia in patients with inflammatory bowel disease treated with ferric carboxymaltose or iron isomaltoside. Aliment Pharmacol Ther. 2019;50:397\u2013406.","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"1802_CR20","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1007\/s00198-017-4189-7","volume":"28","author":"K Briot","year":"2017","unstructured":"Briot K, Geusens P, EmBultink I, Lems WF, Roux C. Inflammatory diseases and bone fragility. Osteoporos Int. 2017;28:3301\u201314.","journal-title":"Osteoporos Int"},{"key":"1802_CR21","doi-asserted-by":"publisher","first-page":"116202","DOI":"10.1016\/j.bone.2021.116202","volume":"154","author":"B Schaefer","year":"2022","unstructured":"Schaefer B, Tobiasch M, Wagner S, et al. Hypophosphatemia after intravenous iron therapy: comprehensive review of clinical findings and recommendations for management. Bone. 2022;154:116202.","journal-title":"Bone"},{"issue":"3","key":"1802_CR22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1136\/flgastro-2019-101260","volume":"11","author":"R Kapasi","year":"2020","unstructured":"Kapasi R, Glatter J, Lamb CA,\u00a0et al. Consensus standards of healthcare for adults and children with inflammatory bowel disease in the UK. Frontline Gastroenterol. 2020;11:178\u201387.","journal-title":"Frontline Gastroenterol"},{"issue":"1","key":"1802_CR23","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/13696998.2024.2444833","volume":"28","author":"TE Detlie","year":"2025","unstructured":"Detlie TE, Karlsen LN, Jorgensen E, Nanu N, Pollock RF. Evaluating the cost-utility of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anaemia in Norway. J Med Econ. 2025;28:291\u2013301.","journal-title":"J Med Econ"},{"issue":"1","key":"1802_CR24","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1080\/13696998.2025.2487359","volume":"28","author":"SC Lindgren","year":"2025","unstructured":"Lindgren SC, Strid H, Hjortswang H, Manxhuka B, Nanu N, Pollock RF. A Swedish cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in the treatment of iron deficiency anemia in patients with inflammatory bowel disease. J Med Econ. 2025;28:567\u201375.","journal-title":"J Med Econ"},{"key":"1802_CR25","doi-asserted-by":"publisher","unstructured":"Rubin DT, Siegel CA, Jairath V,\u00a0et al. Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response. Nat Rev Gastroenterol Hepatol. 2025;22:438-52. https:\/\/doi.org\/10.1038\/s41575-025-01063-x.","DOI":"10.1038\/s41575-025-01063-x"},{"issue":"1","key":"1802_CR26","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s12876-021-02028-5","volume":"21","author":"L Ruiz-Casas","year":"2021","unstructured":"Ruiz-Casas L, Evans J, Rose A,\u00a0et al. The LUCID study: living with ulcerative colitis; identifying the socioeconomic burden in Europe. BMC Gastroenterol. 2021;21:456.","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"1802_CR27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/ecco-jcc\/jjy114","volume":"13","author":"A Sturm","year":"2019","unstructured":"Sturm A, Maaser C, Calabrese E,\u00a0et al. ECCO-ESGAR guideline for diagnostic assessment in IBD Part 2: IBD scores and general principles and technical aspects. J Crohns Colitis. 2019;13:273\u201384.","journal-title":"J Crohns Colitis"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-025-01802-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12664-025-01802-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-025-01802-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T07:31:27Z","timestamp":1778484687000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12664-025-01802-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,14]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1802"],"URL":"https:\/\/doi.org\/10.1007\/s12664-025-01802-7","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,14]]},"assertion":[{"value":"14 June 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JKL declares no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The author is\u00a0responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology\u00a0or the printer\/publishers are responsible for the results\/findings and content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}